AN1
Click for more information
14.3% 0.8¢ anagenics limited

Sorry, link does not workThings starting to add upCELLMID US,...

  1. Pharmargeddon
    3,152 Posts.
    lightbulb Created with Sketch. 335
    clock Created with Sketch.
    01/08/20
    08:01
    Post #: 46233128
    Sorry, link does not work


    Things starting to add up

    CELLMID US, EURO MIDKINE PATENTS CELLMID Cellmid says it has received US and European patents for improved midkine antibodies, which will protect its intellectual property until October 14, 2035. ... volunteers and idiopathic pulmonary fibrosis-interstatial lung disease patients.
    Biotech back issue.

    We are OK to 2035 by the looks on this one.
    CDY Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.001(14.3%) 		Mkt cap ! $3.691M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $1.92K 240K

Buyers (Bids)

No. Vol. Price($)
3 493225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 10.07am 21/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.